Clinical and molecular epidemiology of chromosome-mediated resistance to third-generation cephalosporins in Enterobacter isolates in eastern France

Jarvis, 1992, Predominant pathogens in hospital infections, J Antimicrob Chemother, 29, 19, 10.1093/jac/29.suppl_A.19 Chow, 1991, Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy, Ann Intern Med, 115, 585, 10.7326/0003-4819-115-8-585 Bodey, 1991, Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital, Rev Infect Dis, 13, 550, 10.1093/clinids/13.4.550 Sanders, 1997, Enterobacter spp. pathogens poised to flourish at the turn of the century, Clin Microb Rev, 10, 220, 10.1128/CMR.10.2.220 Bush, 1995, A functional classification scheme for - lactamases and its correlation with molecular structure, Antimicrob Agents Chemother, 39, 1211, 10.1128/AAC.39.6.1211 Sanders, 1992, - lactamase of gram-negative bacteria: new challenges for new drugs, Clin Infect Dis, 14, 1089, 10.1093/clinids/14.5.1089 De Champs, 1991, Concomitant dissemination of three extended-spectrum - lactamases among different Enterobacteriaceae isolated in a French hospital, J Antimicrob Chemother, 27, 441, 10.1093/jac/27.4.441 De Champs, 1989, Prospective survey of colonization and infection caused by expanded-spectrum - lactamase-producing members of the family Enterobacteriaceae in an intensive care unit, J Clin Microbiol, 27, 2887, 10.1128/JCM.27.12.2887-2890.1989 Goldstein, 1993, Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals, J Antimicrob Chemother, 32, 595, 10.1093/jac/32.4.595 Rice, 1990, Outbreak of ceftazidime resistance caused by extended-spectrum - lactamases at a Massachusetts chronic-care facility, Antimicrob Agents Chemother, 34, 2193, 10.1128/AAC.34.11.2193 Hibbert-Rodgers, 1995, Molecular epidemiology of ceftazidime-resistant Enterobacteriaceae from patients on a pediatric oncology ward, J Antimicrob Chemother, 36, 65, 10.1093/jac/36.1.65 De Champs, 1993, Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem, J Clin Microbiol, 31, 123, 10.1128/JCM.31.1.123-127.1993 Jarlier, 1988, Extended broad-spectrum - lactamases conferring transferable resistance to newer - lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility, Rev Infect Dis, 10, 867, 10.1093/clinids/10.4.867 Arpin, 1996, Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit, J Clin Microbiol, 34, 2163, 10.1128/JCM.34.9.2163-2169.1996 Georghiou, 1995, Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques, Clin Infect Dis, 20, 10.1093/clinids/20.1.84 Lucet, 1996, Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition, Clin Infect Dis, 22, 430, 10.1093/clinids/22.3.430 Brun-Buisson, 1987, Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae, Lancet, ii, 302, 10.1016/S0140-6736(87)90891-9 Burã©, 1988, Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam, Eur J Clin Microbiol Infect Dis, 7, 780, 10.1007/BF01975048 Shannon, 1990, Importation of organisms producing broad-spectrum SHV-group - lactamases into the United Kingdom, J Antimicrob Chemother, 25, 343, 10.1093/jac/25.3.343 Monnet, 1997, The National Nosocomial Infections Surveillance System. Evidence of interhospital transmission of extended-spectrum - lactam-resistant Klebsiella pneumoniae in the United States. 1986-93, Infect Control Hosp Epidemiol, 18, 492, 10.2307/30141189 Struelens, 1999, Antibiotic policy: a tool for controlling resistance of hospital pathogens, Clin Microbiol Infect, 5, S19, 10.1111/j.1469-0691.1999.tb00720.x Jacobson, 1995, The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I - lactamase-producing organisms, Clin Infect Dis, 21, 1107, 10.1093/clinids/21.5.1107 1996, Report of the Comité de Lʼnantibiogramme de la Société Francãaise de Microbiologie, Clin Microbiol Infect, 2, S46 Sirot, 1992, Resistance to cefotaxime and seven other - lactams in members of the family Enterobacteriaceae: a 3-year survey in France, Antimicrob Agents Chemother, 36, 1677, 10.1128/AAC.36.8.1677 Haertl, 1993, Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments, J Clin Microbiol, 31, 128, 10.1128/JCM.31.1.128-133.1993 Struelens, 1993, Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting, J Clin Microbiol, 31, 1964, 10.1128/JCM.31.8.1964-1970.1993 Tenover, 1995, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing, J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995 Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Statist Assoc, 53, 457, 10.1080/01621459.1958.10501452 Cutler, 1958, Maximum utilization of the life-table method in analyzing survival, J Chron Dis, 8, 699, 10.1016/0021-9681(58)90126-7 Peto, 1972, Asymptomatically efficient rank invariant test procedures (with discussion), J R Stat Soc, 135, 185 John, 1982, Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance, Rev Infect Dis, 4, 13, 10.1093/clinids/4.1.13 Dworzak, 1987, Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins, Eur J Clin Microbiol, 6, 456, 10.1007/BF02013110 Follath, 1987, Clinical consequences of development of resistance to third-generation cephalosporins, Eur J Clin Microbiol, 6, 446, 10.1007/BF02013108 Snydman, 1991, Clinical implications of multi-drug resistance in the intensive care unit, Scand J Infect Dis, 7, 54 Jones, 1992, The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens, Diagn Microbiol Infect Dis, 15, 3S Ballow, 1992, Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group, Diagn Microbiol Infect Dis, 15, 37S Burwen, 1994, National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States, J Infect Dis, 170, 1622, 10.1093/infdis/170.6.1622 Nicolle, 1988, Prior antimicrobial therapy and resistance of Enterobacter Citrobacter and Serratia to third-generation cephalosporins, J Hosp Infect, 11, 321, 10.1016/0195-6701(88)90084-9 Sanders, 1988, Inducible - lactamases: clinical and epidemiologic implications for use of newer cephalosporins, Rev Infect Dis, 10, 830, 10.1093/clinids/10.4.830 Sanders, 1983, Emergence of resistance during therapy with newer - lactam antibiotics: role of inducible - lactamases and implications for the future, Rev Infect Dis, 5, 639, 10.1093/clinids/5.4.639 Olson, 1983, Broad-spectrum - lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance, J Antimicrob Chemother, 11, 299, 10.1093/jac/11.4.299 Johnson, 1990, Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy, J Infect Dis, 162, 981, 10.1093/infdis/162.4.981 Hobson, 1996, An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland, J Hosp Infect, 33, 259, 10.1016/S0195-6701(96)90011-0 Meyer, 1993, Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins, Ann Intern Med, 119, 353, 10.7326/0003-4819-119-5-199309010-00001 Antaniadou, 1997, Restriction policy and strict monitoring of quinolone usage may decrease resistance in the hospital [abstract E-11], 115 White, 1997, Effects of requiring prior authorization for selected antimicrobials; expenditures, susceptibilities and clinical outcomes, Clin Infect Dis, 25, 230, 10.1086/514545 Milatovic, 1987, Development of resistance during antibiotic therapy, Eur J Clin Microbiol, 6, 234, 10.1007/BF02017607 Sanders, 1985, Microbial resistance to newer generation - lactam antibiotics: clinical and laboratory implications, J Infect Dis, 151, 399, 10.1093/infdis/151.3.399 Weinstein, 1985, Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients, Chemoterapia, 4, 110